FDA Milestones: When GLP-1 Medications Entered the Market Byetta (exenatide), a GLP-1 receptor agonist, became the first medication in this class to receive FDA approval in April 2005
Late-stage trifluoromethylthiolation of benzylic CH bonds
Potential Key Benefits*: Encourages collagen and elastin production May reduce fine lines and wrinkles May improve skin texture and firmness Supports enhanced wound healing and scar reduction May promote hair growth and thickness Made in America in a cGMP Facility Questions or Concerns
Non-coding RNAs The regulatory role of non-coding RNAs (ncRNAs) in pyroptosis is of significant interest in the context of NASH
Cognitive Enhancement: Peptide therapy can support cognitive health, improve focus, and boost memory, particularly as one ages
GSH Nebraska: general info + transporters Comprehensive reviews The Incomplete Glutathione Puzzle: Just Guessing at Numbers and Figures?2017 Tissue distribution and concentration 2-5 mM according to the tissue (5 mM = 1,5366 mg/ml) half-life GSH half life It ranges from 3/5 hours to 30/50 hours If we assume 40kg tissues with an average 2.5 mM GSH (ca 750 mg/l) it means 30 g GSH in the whole body with an half-life of 48hours its life is around 10 days